CHEK2 and breast cancer: The odds ratios we observed for HiQ-damaging and HiQ-tolerated variants are each similar to the confidence interval for breast cancer odds ratio (1.2–1.77) reported recently for CHEK2 missense variants in an overlapping cohort.55